Featured Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics By Max ChenAugust 4, 2022
ETF Building Blocks Channel SBIO Increases on Biotech’s Sustained Rebound By Elle CarusoJuly 20, 2022
ETF Building Blocks Channel SBIO Continues Rally on Breakthrough Drug Data By Elle CarusoJune 29, 2022
ETF Building Blocks Channel Biotech Stocks, ETFs Starting to Look Healthier By Tom LydonMarch 21, 2022
ETF Building Blocks Channel SBIO Is a Good Place to Be for Biotech Innovation By Tom LydonFebruary 28, 2022
ETF Building Blocks Channel Consolidation Could Come Calling for Biotech in 2022 By Tom LydonJanuary 5, 2022
ETF Building Blocks Channel Pfizer Vaccine Should Work Against Omicron, Just Less Efficiently By Karrie GordonNovember 30, 2021